When a factory in China was once seen as a cost advantage, Kao Yung-chung watched that calculus flip. The chairman of IntelliEPI Technology — a Taiwan-listed compound semiconductor epitaxy company headquartered in Allen, Texas — recalls how the same overseas facility that once signaled efficiency to customers could, after the US-China tech competition intensified and COVID-era supply chain shocks hit, read instead as a risk.
IntelliEPI previously operated a presence in China. It was suspended during the pandemic and subsequently shut down. Kao did not frame the closure as "bringing production back to the US." The company had always been built around its American base. What changed was the world around it — and what the American base was now worth.
The InP Shortage Was a Perfect Storm, Not Just a Policy Problem
The tightening of indium phosphide (InP) supply has attracted wide attention, with many pointing to Chinese export controls on related materials as the primary cause. Kao pushed back on that framing.
Export controls amplified a problem that was already developing, he argued. The real driver was that AI-generated demand for InP-based optical components — high-speed lasers, photodetectors, and modulators used in data center interconnects — outpaced global material capacity well before any regulatory intervention. Expanding an epitaxial wafer production line is not like spinning up a software service. It requires equipment procurement, process tuning, yield stabilization, and customer qualification. That process typically takes years. When the AI optical communications market turned sharply between late 2024 and 2025, the supply chain had no meaningful buffer.
"I called it a Perfect Storm," Kao said. Even absent export restrictions, InP would likely have been scarce. What the controls added was a qualitatively different kind of pressure: not simply a shortage, but uncertainty about when supply would normalize, how much would be available, and what the rules might look like next time.
IntelliEPI Moves to Build a Second InP Source Before the Next Shortage
Rather than waiting for an alternative supplier to emerge on its own, IntelliEPI has partnered with a German materials company to establish a second source for InP substrates, outside the market's dominant supplier Sumitomo Electric. The strategy is deliberately early: instead of placing orders once the new supplier reaches commercial maturity, IntelliEPI is actively contributing its own expertise in epitaxy, equipment operation, and materials use to help the partner address production scale-up and quality consistency challenges.
"Real resilience isn't buying more inventory," Kao said. "It's joining the supply chain before it forms."
The same thinking drove IntelliEPI's share-swap alliance with Guangsheng (光聖, stock code 6442), a Taiwan-based maker of optical transceiver components and modules. The two companies occupy complementary positions in the AI supply chain: IntelliEPI operates upstream in compound semiconductor epitaxy and materials; Guangsheng sits closer to optical modules and large end customers. Their strategic alliance is structured around exchanging market intelligence, connecting overseas resources, and identifying early collaboration opportunities in silicon photonics, InP components, and AI data center procurement.
Kao described the share swap not as a financial investment but as a means of integrating the company into a broader, more resilient cooperation network — with partners who can start talking before demand specifications are even fully defined.
A $60 Million Allen Expansion, Backed by CHIPS Act and Texas State Funding
IntelliEPI plans to invest approximately $60 million in its Allen, Texas facility — upgrading MBE equipment, expanding production capacity, and constructing additional space. At the time of the interview, a federal direct subsidy agreement under the US CHIPS and Science Act was in its final stages of processing; a grant from the Texas Semiconductor Innovation Fund (TSIF) had already been secured and will support the Allen expansion.
Kao recalled that when the team began planning the investment in 2022, there were internal questions about whether the additional capacity would come too early. The AI demand signal did not become clearly legible until 2025. What the US policy framework is trying to rebuild, in his view, goes beyond wafer fabrication: it is a complete, verifiable chain from materials and equipment through to defense-grade applications, produced in regions where supply reliability can be confirmed.
In Defense Supply Chains, Governance Is a Technical Requirement
IntelliEPI's customer base spans both commercial optical communications and US aerospace and defense clients — an exposure that has given Kao an early window into how defense procurement evaluates suppliers differently from commercial channels.
Meeting the technical specification, he noted, is only the first condition. Defense and aerospace customers also scrutinize board composition, ownership structure, corporate governance policies, information security practices, and long-term delivery records. A company that can manufacture the required material but cannot demonstrate organizational continuity and appropriate controls will not advance in the evaluation, regardless of technical capability.
This context informs IntelliEPI's measured approach to strategic partnerships and equity arrangements. In an era when compound semiconductor materials — InP, gallium nitride, gallium arsenide, and antimonide-based materials used in infrared sensing — have been drawn into national security and supply chain policy discussions, Kao's framing of resilience is consistent: the companies that will matter are not those that react to disruption after it occurs, but those that established second sources, regional capacity, and trusted partnerships before the crisis arrived.
